| Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples R Walsh, KL Thomson, JS Ware, BH Funke, J Woodley, KJ McGuire, ... Genetics in Medicine 19 (2), 192-203, 2017 | 669 | 2017 |
| Shared genetic predisposition in peripartum and dilated cardiomyopathies JS Ware, J Li, E Mazaika, CM Yasso, T DeSouza, TP Cappola, EJ Tsai, ... New England Journal of Medicine 374 (3), 233-241, 2016 | 466 | 2016 |
| Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease AM Roberts, JS Ware, DS Herman, S Schafer, J Baksi, AG Bick, ... Science translational medicine 7 (270), 270ra6-270ra6, 2015 | 445 | 2015 |
| Titin-truncating variants affect heart function in disease cohorts and the general population S Schafer, A De Marvao, E Adami, LR Fiedler, B Ng, E Khin, ... Nature genetics 49 (1), 46-53, 2017 | 289 | 2017 |
| Evidence-based assessment of genes in dilated cardiomyopathy E Jordan, L Peterson, T Ai, B Asatryan, L Bronicki, E Brown, R Celeghin, ... Circulation 144 (1), 7-19, 2021 | 266 | 2021 |
| Reevaluating the genetic contribution of monogenic dilated cardiomyopathy F Mazzarotto, U Tayal, RJ Buchan, W Midwinter, A Wilk, N Whiffin, ... Circulation 141 (5), 387-398, 2020 | 182 | 2020 |
| Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect R Tadros, C Francis, X Xu, AMC Vermeer, AR Harper, R Huurman, ... Nature genetics 53 (2), 128-134, 2021 | 173 | 2021 |
| Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy R Walsh, F Mazzarotto, N Whiffin, R Buchan, W Midwinter, A Wilk, N Li, ... Genome medicine 11, 1-18, 2019 | 114 | 2019 |
| Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death R Walsh, A Adler, AS Amin, E Abiusi, M Care, H Bikker, S Amenta, ... European heart journal 43 (15), 1500-1510, 2022 | 70 | 2022 |
| Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies F Mazzarotto, MH Hawley, M Beltrami, L Beekman, A De Marvao, ... Genetics in Medicine 23 (5), 856-864, 2021 | 68 | 2021 |
| Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls R Walsh, N Lahrouchi, R Tadros, F Kyndt, C Glinge, PG Postema, ... Genetics in medicine 23 (1), 47-58, 2021 | 65 | 2021 |
| Comparison of long‐term outcome in anthracycline‐related versus idiopathic dilated cardiomyopathy: a single centre experience A Fornaro, I Olivotto, L Rigacci, M Ciaccheri, B Tomberli, C Ferrantini, ... European Journal of Heart Failure 20 (5), 898-906, 2018 | 65 | 2018 |
| Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center F Mazzarotto, F Girolami, B Boschi, F Barlocco, A Tomberli, K Baldini, ... Genetics in Medicine 21 (2), 284-292, 2019 | 61 | 2019 |
| Contemporary insights into the genetics of hypertrophic cardiomyopathy: toward a new era in clinical testing? F Mazzarotto, I Olivotto, B Boschi, F Girolami, C Poggesi, PJR Barton, ... Journal of the American Heart Association 9 (8), e015473, 2020 | 60 | 2020 |
| Phenotypic expression and outcomes in individuals with rare genetic variants of hypertrophic cardiomyopathy A de Marvao, KA McGurk, SL Zheng, M Thanaj, W Bai, J Duan, C Biffi, ... Journal of the American College of Cardiology 78 (11), 1097-1110, 2021 | 57 | 2021 |
| Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy AS Helms, AD Thompson, AA Glazier, N Hafeez, S Kabani, J Rodriguez, ... Circulation: Genomic and Precision Medicine 13 (5), 396-405, 2020 | 52 | 2020 |
| Temporal trend of age at diagnosis in hypertrophic cardiomyopathy: an analysis of the international sarcomeric human cardiomyopathy registry M Canepa, C Fumagalli, G Tini, J Vincent-Tompkins, SM Day, EA Ashley, ... Circulation: Heart Failure 13 (9), e007230, 2020 | 52 | 2020 |
| Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions X Zhang, R Walsh, N Whiffin, R Buchan, W Midwinter, A Wilk, R Govind, ... Genetics in Medicine 23 (1), 69-79, 2021 | 40 | 2021 |
| A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy T Smole, B Žunkovič, M Pičulin, E Kokalj, M Robnik-Šikonja, M Kukar, ... Computers in biology and medicine 135, 104648, 2021 | 38 | 2021 |
| A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy C Horvat, R Johnson, L Lam, J Munro, F Mazzarotto, AM Roberts, ... Genetics in Medicine 21 (1), 133-143, 2019 | 34 | 2019 |
